These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3505198)

  • 21. The effects of calcitonin on bone resorption in hyperthyroidism: a placebo-controlled clinical study.
    Akçay MN; Akçay G; BIlen H
    J Bone Miner Metab; 2004; 22(2):90-3. PubMed ID: 14999518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
    Singh AK; Avula S; Kher V; Rao DS; Mithal A
    Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detrimental effect of hypophosphatemia on the severity and progression of ischemic acute renal failure.
    Lumlertgul D; Harris DC; Burke TJ; Schrier RW
    Miner Electrolyte Metab; 1986; 12(3):204-9. PubMed ID: 3724706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of Tricresyl Phosphate (CAS No. 1330-78-5) in F344/N Rats and B6C3F1 Mice (Gavage and Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Sep; 433():1-321. PubMed ID: 12616298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphate-restricted diets versus calcitonin in the prevention of osteodystrophy in experimental renal disease.
    D'Angelo A; Bonucci E; Ballanti P; Fabris A; Giannini S; Ferrarese P; Vassanelli P; Maschio G
    Adv Exp Med Biol; 1984; 178():233-40. PubMed ID: 6507158
    [No Abstract]   [Full Text] [Related]  

  • 26. Responses to salmon calcitonin in chronic renal failure: relation to histological and biochemical indices of bone turnover.
    Cundy T; Heynen G; Gaspar S; Earnshaw M; Bartlett M; Paton S; Kanis JA
    Eur J Clin Invest; 1981 Jun; 11(3):177-84. PubMed ID: 6791936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin.
    Kanis JA; Earnshaw M; Heynen G; Ledingham JG; Oliver DO; Russell GG; Woods CG; Franchimont P; Gaspar S
    N Engl J Med; 1977 May; 296(19):1073-9. PubMed ID: 850517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of phosphate in the potentiation or amelioration of acute renal failure.
    Dobyan DC; Bulger RE; Eknoyan G
    Miner Electrolyte Metab; 1991; 17(2):112-5. PubMed ID: 1753919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that endogenous calcitonin protects against renal bone disease.
    Kanis JA; Oliver D; Ledingham JC; Russell RG
    Lancet; 1976 Dec; 2(7999):1322-6. PubMed ID: 63802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production and degradation of calcitriol in renal failure rats.
    Hsu CH; Patel S; Young EW; Simpson RU
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F1015-9. PubMed ID: 3688232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silicon level in rats with chronic renal failure produced by 5/6 nephrectomy.
    Hosokawa S; Yoshida O
    Nephron; 1995; 69(3):301-4. PubMed ID: 7753264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
    Kanis JA; Earnshaw M; Heynen G; Russell RG; Woods CG
    Calcif Tissue Res; 1977 May; 22 Suppl():147-53. PubMed ID: 912516
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute responsiveness to calcitonin in chronic renal failure.
    Cochran M; Hillyard CJ; Dew GJ; Martin TJ
    Br Med J; 1976 Aug; 2(6032):396-8. PubMed ID: 947443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphate depletion arrests progression of chronic renal failure independent of protein intake.
    Lumlertgul D; Burke TJ; Gillum DM; Alfrey AC; Harris DC; Hammond WS; Schrier RW
    Kidney Int; 1986 Mar; 29(3):658-66. PubMed ID: 3702220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effect of moderate protein restriction on growth, renal function and survival in young rats with chronic renal failure.
    Friedman AL; Pityer R
    J Nutr; 1986 Dec; 116(12):2466-77. PubMed ID: 3806243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of phosphate-induced progression of uremia in rats by 3-phosphocitric acid.
    Gimenez L; Walker WG; Tew WP; Hermann JA
    Kidney Int; 1982 Jul; 22(1):36-41. PubMed ID: 7120753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcitonin-induced hypocalcaemia as a possible index of osteoclastic activity in patients with chronic renal failure.
    Del Río A; Rico H; Bordiu E; Novoa D
    Nephron; 1987; 47(4):241-5. PubMed ID: 3696325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethanol induced secretion of calcitonin in chronic renal disease.
    Kanis JA; Adams ND; Cecchettin M; Luizetto G; Gaspar S; Heynen G
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):155-61. PubMed ID: 428114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma calcitonin in rats with renal failure.
    Onishi T; Deftos LJ
    Calcif Tissue Int; 1988 Mar; 42(3):181-4. PubMed ID: 3130166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of a low-phosphate diet on hematocrit and oxygen transport in uremic rats.
    Connelly TJ; Caro J; Erslev AJ; Silver R
    Am J Hematol; 1982 Feb; 12(1):55-61. PubMed ID: 7064985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.